FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2968482839> ?p ?o ?g. }

• W2968482839 endingPage "85" @default.
• W2968482839 startingPage "80" @default.
• W2968482839 abstract "Objectives Lung cancer has the highest incidence and fatality among all cancers. Our research analyzed the expression of galectin-9 on non-small cell lung cancer (NSCLC) tumor cells and tumor infiltrating lymphocytes (TILs). Materials and methods We analyzed the expression level of galectin-9 protein in 136 NSCLC primary tumor samples by immunohistochemistry (IHC). Results We tested 136 surgical resected primary NSCLC tumor tissues for galectin-9 from Medical University of Gdansk, Poland. We found that on tumor cells, galectin-9 level only had correlation with T cell immunoglobulin and mucin-domain containing-3 (TIM-3) level (Correlation Coefficient = 0.360, p < 0.001). On TILs, galectin-9 level had broad connections with other checkpoints including programmed cell death protein-1 (PD-1) (Correlation Coefficient = 0.332, p < 0.001), programmed cell death-ligand 1 (PD-L1) (Correlation Coefficient = 0.247, p = 0.004) and TIM-3 (Correlation Coefficient = 0.350, p < 0.001). Interestingly, galectin-9 level on TILs also had positive relation with PD-L1 level on tumor cells (Correlation Coefficient = 0.278, p = 0.001), galectin-9 level on tumor cells (Correlation Coefficient = 0.181, p = 0.035) and TIL percentage (Correlation Coefficient = 0.236, p = 0.006). High level of galectin-9 on TILs indicated shorter RFS (recurrence-free survival) (RFS 1.82 years, 95% CI 0.795–2.845 vs. 0.67 years, 95% CI 0.086–1.254, P = 0.033). Patients with galectin-9 positive tumor cells display longer overall survival (OS) (1.76 years, 95% CI 0.222–3.298 vs. 3.10 years, 95% CI 2.662–3.538, P = 0.039) Conclusions We found galectin-9 expression on both NSCLC tumor cells and TILs. Galectin-9 expression was found in all NSCLC pathological type. Galectin-9 level on TILs had correlation with TIM-3, PD-1 and PD-L1 level. On tumor cells, galectin-9 level had correlation with TIM-3 level. Patients with low galectin-9 level on tumor cells or high galectin-9 level on TILs were more likely to have poor prognosis." @default.
• W2968482839 created "2019-08-22" @default.
• W2968482839 creator A5002907962 @default.
• W2968482839 creator A5006820907 @default.
• W2968482839 creator A5016911330 @default.
• W2968482839 creator A5029378981 @default.
• W2968482839 creator A5031903520 @default.
• W2968482839 creator A5056995229 @default.
• W2968482839 creator A5070885335 @default.
• W2968482839 creator A5071851332 @default.
• W2968482839 creator A5080102032 @default.
• W2968482839 date "2019-10-01" @default.
• W2968482839 modified "2023-10-15" @default.
• W2968482839 title "Galectin-9 in non-small cell lung cancer" @default.
• W2968482839 cites W1224937636 @default.
• W2968482839 cites W1460212253 @default.
• W2968482839 cites W1915191412 @default.
• W2968482839 cites W1965330885 @default.
• W2968482839 cites W1969925688 @default.
• W2968482839 cites W1976105607 @default.
• W2968482839 cites W1976696689 @default.
• W2968482839 cites W1994238092 @default.
• W2968482839 cites W2014392340 @default.
• W2968482839 cites W2021551516 @default.
• W2968482839 cites W2025496457 @default.
• W2968482839 cites W2062037349 @default.
• W2968482839 cites W2068473916 @default.
• W2968482839 cites W2070631889 @default.
• W2968482839 cites W2079025114 @default.
• W2968482839 cites W2098414192 @default.
• W2968482839 cites W2132543133 @default.
• W2968482839 cites W2158348986 @default.
• W2968482839 cites W2171639208 @default.
• W2968482839 cites W2180340557 @default.
• W2968482839 cites W2210071992 @default.
• W2968482839 cites W2470583568 @default.
• W2968482839 cites W2561784300 @default.
• W2968482839 cites W2569464488 @default.
• W2968482839 cites W2741601602 @default.
• W2968482839 cites W2753788855 @default.
• W2968482839 cites W2762777471 @default.
• W2968482839 cites W2803076413 @default.
• W2968482839 cites W2908928362 @default.
• W2968482839 cites W2911188335 @default.
• W2968482839 doi "https://doi.org/10.1016/j.lungcan.2019.08.014" @default.
• W2968482839 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31454748" @default.
• W2968482839 hasPublicationYear "2019" @default.
• W2968482839 type Work @default.
• W2968482839 sameAs 2968482839 @default.
• W2968482839 citedByCount "31" @default.
• W2968482839 countsByYear W29684828392019 @default.
• W2968482839 countsByYear W29684828392020 @default.
• W2968482839 countsByYear W29684828392021 @default.
• W2968482839 countsByYear W29684828392022 @default.
• W2968482839 countsByYear W29684828392023 @default.
• W2968482839 crossrefType "journal-article" @default.
• W2968482839 hasAuthorship W2968482839A5002907962 @default.
• W2968482839 hasAuthorship W2968482839A5006820907 @default.
• W2968482839 hasAuthorship W2968482839A5016911330 @default.
• W2968482839 hasAuthorship W2968482839A5029378981 @default.
• W2968482839 hasAuthorship W2968482839A5031903520 @default.
• W2968482839 hasAuthorship W2968482839A5056995229 @default.
• W2968482839 hasAuthorship W2968482839A5070885335 @default.
• W2968482839 hasAuthorship W2968482839A5071851332 @default.
• W2968482839 hasAuthorship W2968482839A5080102032 @default.
• W2968482839 hasConcept C121608353 @default.
• W2968482839 hasConcept C126322002 @default.
• W2968482839 hasConcept C142724271 @default.
• W2968482839 hasConcept C143998085 @default.
• W2968482839 hasConcept C204232928 @default.
• W2968482839 hasConcept C2776256026 @default.
• W2968482839 hasConcept C2776336362 @default.
• W2968482839 hasConcept C2777701055 @default.
• W2968482839 hasConcept C2778326572 @default.
• W2968482839 hasConcept C502942594 @default.
• W2968482839 hasConcept C71924100 @default.
• W2968482839 hasConceptScore W2968482839C121608353 @default.
• W2968482839 hasConceptScore W2968482839C126322002 @default.
• W2968482839 hasConceptScore W2968482839C142724271 @default.
• W2968482839 hasConceptScore W2968482839C143998085 @default.
• W2968482839 hasConceptScore W2968482839C204232928 @default.
• W2968482839 hasConceptScore W2968482839C2776256026 @default.
• W2968482839 hasConceptScore W2968482839C2776336362 @default.
• W2968482839 hasConceptScore W2968482839C2777701055 @default.
• W2968482839 hasConceptScore W2968482839C2778326572 @default.
• W2968482839 hasConceptScore W2968482839C502942594 @default.
• W2968482839 hasConceptScore W2968482839C71924100 @default.
• W2968482839 hasFunder F4320321001 @default.
• W2968482839 hasLocation W29684828391 @default.
• W2968482839 hasLocation W29684828392 @default.
• W2968482839 hasOpenAccess W2968482839 @default.
• W2968482839 hasPrimaryLocation W29684828391 @default.
• W2968482839 hasRelatedWork W2034169702 @default.
• W2968482839 hasRelatedWork W2101676003 @default.
• W2968482839 hasRelatedWork W2168064072 @default.
• W2968482839 hasRelatedWork W2355920994 @default.
• W2968482839 hasRelatedWork W2376996112 @default.
• W2968482839 hasRelatedWork W2399421402 @default.

• next